We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US FDA Mandates Wording to Revise Informed Consent Forms for Trials
US FDA Mandates Wording to Revise Informed Consent Forms for Trials
February 9, 2011
Clinical trial sponsors have until March 7, 2012, to modify their informed consent forms in compliance with a new rule from the U.S. Food and Drug Administration (FDA).
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor